Manish Kumar | Bioinorganic Chemistry | Best Researcher Award

Published on by Cell Biologist

Dr. Manish Kumar | Bioinorganic Chemistry | Best Researcher Award

Delhi University | India

Dr. Manish Kumar is an accomplished inorganic chemist whose research centers on coordination chemistry, organometallic chemistry, and bioinorganic chemistry, with special emphasis on designing fluorescent chemo-sensors and metal complexes for biological applications. He completed his Ph.D. at the University of Delhi, where he investigated the synthesis and characterization of metal complexes built on quinolone derivatives and heterocyclic ligands, and extensively studied their DNA/protein binding, cleavage, docking, and in vitro cytotoxicity. Over the years, he has published a number of peer-reviewed articles in journals including New Journal of Chemistry, Dalton Transactions, Inorganica Chimica Acta, Spectrochimica Acta A, and Polyhedron. His works explore the structure–activity relationships of complexes of Ni(II), Cu(II), and Ru(II), combining experimental methods, X-ray crystallography, spectroscopic techniques, thermodynamics, molecular docking, and theoretical (DFT) studies. He has also contributed a book chapter on metallodrugs in medicinal inorganic chemistry. His research has attracted citations across the field, earning him an h-index of about [insert h-index] and a total of [insert total citations] citations to date. Through his efforts, he continues to advance the frontiers of metallodrug design, metal–biomolecule interaction, and sensor development in inorganic chemistry.

Profile: Scopus

Featured Publications:

Kumar, M., Lal, N., Luthra, P. M., & Masram, D. T. (2021). Exploring binding plus cleavage activities of Nickel(II) complexes towards DNA and proteins. New Journal of Chemistry, 45(15), 6693–6708.

Kumar, M., Kumar, G., & Masram, D. T. (2020). Copper(II) complexes containing enoxacin and heterocyclic ligands: Synthesis, crystal structures and their biological perspectives. New Journal of Chemistry, 44(20), 8595–8613.

Kumar, G., Mogha, N. K., Kumar, M., & Masram, D. T. (2020). NiO nanocomposites/rGO as a heterogeneous catalyst for imidazole scaffolds with applications in inhibiting the DNA binding activity. Dalton Transactions, 49(6), 1963–1974.

Kumar, M., Kumar, G., Dadure, K. M., & Masram, D. T. (2019). Copper(II) complexes based on levofloxacin and 2N-donor ligands: Synthesis, crystal structures and in vitro biological evaluation. New Journal of Chemistry, 43(40), 15462–15481.

Kumar, G., Kant, A., Kumar, M., & Masram, D. T. (2019). Synthesis, characterization and kinetic study of metal organic framework nanocomposite excipient used as extended release delivery vehicle for an antibiotic drug. Inorganica Chimica Acta, 496, 119036.

Kumar, M., Mogha, N. K., Kumar, G., Hussain, F., & Masram, D. T. (2019). Biological evaluation of copper(II) complex with nalidixic acid and 2,2′-bipyridine (bpy). Inorganica Chimica Acta, 490, 144–154.

Kumar, M., Kumar, G., Mogha, N. K., Jain, R., Hussain, F., & Masram, D. T. (2019). Structure, DNA/proteins binding, docking and cytotoxicity studies of copper(II) complexes with the first quinolone drug nalidixic acid and 2,2′-dipyridylamine. Spectrochimica Acta Part A: Molecular and Biomolecular Spectroscopy, 212, 94–104.

Kumar, M., & Masram, D. T. (2019). Evaluation of DNA, BSA, and HSA binding propensity of copper(II) complex with N-donor ligand 2,2′-dipyridylamine. Polyhedron, 157, 511–520.

Amirhosein Kefayat | Cancer Cells | Best Researcher Award

Published on by Cell Biologist

Dr. Amirhosein Kefayat | Cancer Cells | Best Researcher Award

Edinburgh of University | United Kingdom

Dr. Amirhosein Kefayat is a clinical research fellow at the Institute of Genetics and Cancer, University of Edinburgh, with over fourteen years of dedicated experience in translational and clinical cancer research. Since his early days in medical school, he has pursued a strong passion for advancing oncology through both laboratory and clinical investigations, contributing to more than 60 peer-reviewed publications that have collectively garnered over 2,300 citations, with a Google Scholar H-index of 28. His research spans biomaterials, nanomedicine, wound healing, immunoinformatics, and cancer vaccine design, with several of his papers ranking among the top 1% most-cited in their respective years of publication. Notably, his work on innovative wound dressings, cancer-testis antigen vaccines, and gold nanoclusters for radiosensitization has made significant impacts within the fields of biomaterials and cancer therapeutics. Alongside his research, he is currently advancing his academic qualifications through a Postgraduate Certificate of Academic Practice at the University of Edinburgh and Associate Principal Investigator Training with NIHR. Recognized among the top 0.5% of cancer researchers worldwide, his career reflects a consistent commitment to bridging basic science and clinical application to improve patient care.

Profiles: Google Scholar | Scopus | Orcid

Featured Publications:

Eskandarinia, A., Kefayat, A., Agheb, M., Rafienia, M., Amini Baghbadorani, M., & Navid, S. (2020). A novel bilayer wound dressing composed of a dense polyurethane/propolis membrane and a biodegradable polycaprolactone/gelatin nanofibrous scaffold. Scientific Reports, 10(1), 3063.

Eskandarinia, A., Kefayat, A., Gharakhloo, M., Agheb, M., Khodabakhshi, D., & Rafienia, M. (2020). A propolis enriched polyurethane-hyaluronic acid nanofibrous wound dressing with remarkable antibacterial and wound healing activities. International Journal of Biological Macromolecules, 149, 467–476.

Safavi, A., Kefayat, A., Mahdevar, E., Abiri, A., & Ghahremani, F. (2020). Exploring the out of sight antigens of SARS-CoV-2 to design a candidate multi-epitope vaccine by utilizing immunoinformatics approaches. Vaccine, 38(48), 7612–7628.

Khodabakhshi, D., Eskandarinia, A., Kefayat, A., Rafienia, M., Navid, S., & Karbasi, S. (2019). In vitro and in vivo performance of a propolis-coated polyurethane wound dressing with high porosity and antibacterial efficacy. Colloids and Surfaces B: Biointerfaces, 178, 177–184.

Eskandarinia, A., Kefayat, A., Rafienia, M., Agheb, M., Navid, S., & Ebrahimpour, K. (2019). Cornstarch-based wound dressing incorporated with hyaluronic acid and propolis: In vitro and in vivo studies. Carbohydrate Polymers, 216, 25–35.

Rosa M Giraldez-Perez | Intracellular Transport Systems | Innovative Research Award

Published on by Cell Biologist

Prof. Dr. Rosa M Giraldez-Perez | Intracellular Transport Systems | Innovative Research Award

University or Cordoba | Spain

Rosa María Giráldez-Pérez is a researcher in the fields of nanotechnology, nanomedicine, physiology, and neuroscience whose scientific contributions focus on the design and application of nanomaterials for therapeutic purposes. Her work has addressed innovative strategies such as gold nanosystems functionalized with antibiotics or anticancer drugs, the development of nanocarriers for leukemia, prostate, liver, and lung cancer treatments, as well as nanoparticle-based approaches to prevent antibiotic resistance. She has also contributed to research in obesity therapy through nanosystems targeting metabolic regulation and in neuroscience through studies on oxidative stress and fragile X syndrome. Her research output includes 81 scientific documents, which have accumulated 911 citations and reflect an h-index of 13, demonstrating both productivity and impact in her field. A significant portion of her publications are in high-impact journals indexed in the Journal Citation Reports (JCR), and several list her as first or senior author, highlighting her leading role in collaborative projects. By integrating expertise from cellular biology, physiology, and nanoscience, her work advances translational biomedical research and offers potential therapeutic solutions for cancer, infectious diseases, metabolic disorders, and neurological conditions.

Profiles: Orcid | Scopus

Featured Publications:

Giráldez-Pérez, R. M., Grueso, E. M., Montero-Hidalgo, A. J., Muriana-Fernández, C., Kuliszewska, E., Luque, R. M., & Prado-Gotor, R. (2025). Daunomycin nanocarriers with high therapeutic payload for the treatment of childhood leukemia. Pharmaceutics, 17(9), 1236.

De Diego-Otero, Y., El Bekay, R., García-Guirado, F., Sánchez-Salido, L., & Giráldez-Pérez, R. M. (2024). Apocynin, a selective NADPH oxidase (Nox2) inhibitor, ameliorates behavioural and learning deficits in the fragile X syndrome mouse model. Biomedicines, 12(2887).

Lhamyani, S., Gentile, A. M., Mengual-Mesa, M., Grueso, E., Giráldez-Pérez, R. M., Fernandez-Garcia, J. C., … El Bekay, R. (2024). Au@16-pH-16/miR-21 mimic nanosystem: An efficient treatment for obesity through browning and thermogenesis induction. Biomedicine & Pharmacotherapy, 171, 116104.

Giráldez-Pérez, R. M., Grueso-Molina, E. M., Carbonero-Martínez, A., Álvarezmárquez, J., Kuliszewska, E., Gordillo-Macías, M., & Prado-Gotor, R. (2023). Synergistic antibacterial effects of amoxicillin and gold nanoparticles: A therapeutic option to combat antibiotic resistance. Antibiotics, 12(8), 81275.

Giráldez-Pérez, R. M., Grueso, E., Montero-Hidalgo, A. J., Luque, R. M., Carnerero, J. M., Kuliszewska, E., & Prado-Gotor, R. (2022). Gold nanosystems covered with doxorubicin/DNA complexes: A therapeutic target for prostate and liver cancer. International Journal of Molecular Sciences, 23(24), 15575.

Giráldez-Pérez, R. M., Grueso, E. M., Jiménez-Aguayo, R., Carbonero, A., González-Bravo, M., Kuliszewska, E., & Prado-Gotor, R. (2022). Use of nanoparticles to prevent resistance to antibiotics: Synthesis and characterization of gold nanosystems based on tetracycline. Pharmaceutics, 14(9), 1941.

Lhamyani, S., Gentile, A. M., Giráldez-Pérez, R. M., et al. (2021). miR-21 mimic blocks obesity in mice: A novel therapeutic option. Molecular Therapy – Nucleic Acids, 26, 401–416. h

Grueso-Molina, E. M., Giráldez-Pérez, R. M., Kuliszewska, E., Guerrero, J. A., & Prado-Gotor, R. (2021). Reversible cationic gemini surfactant-induced aggregation of anionic gold nanoparticles for sensing biomolecules. Colloids and Surfaces A: Physicochemical and Engineering Aspects, 610, 125893.

Gomes, A., Carnerero-Panduro, J. M., Jiménez-Ruiz, A., Grueso-Molina, E. M., Giráldez-Pérez, R. M., & Prado-Gotor, R. (2021). Lysozyme-AuNPs interactions: Determination of binding free energy. Nanomaterials, 11(8), 2139.

Giráldez-Pérez, R. M., Grueso-Molina, E. M., Domínguez-García, I., Pastor-Carrillo, N. M., Kuliszewska, E., & Prado-Gotor, R. (2021). Biocompatible DNA/5-fluorouracil gemini surfactant-functionalized gold nanoparticles as promising vectors in lung cancer therapy. Pharmaceutics, 13(3), 423.

Giuseppe | Gene Regulation Epigenetics | Outstanding Scientist Award

Published on by Cell Biologist

Prof. Dr. Giuseppe | Gene Regulation Epigenetics | Outstanding Scientist Award

Istituto di Ricerche Farmacologiche Mario Negri | Italy

Dr. Giuseppe Remuzzi, an Italian physician and researcher with long career in nephrology and internal medicine, obtained his M.D. cum laude from the University of Pavia in 1974, followed by specializations in Laboratory and Clinical Hematology (1977) and in Clinical Nephrology (cum laude, 1980) from University of Milan. He held positions as Resident Fellow in Internal Medicine at Ospedale Briolini, Gazzaniga; then Assistant Professor and later Associate Professor in Nephrology and Dialysis at Ospedali Riuniti, Bergamo; he also did research fellowships in the U.K. at Babraham (Cambridge) and Guy’s Hospital Medical School (London). His research broadly spans kidney disease, clinical nephrology, molecular‐and pathophysiological mechanisms of renal injury, and translational studies. According to Google Scholar, Remuzzi has an h-index of 232, has published thousands of scholarly documents, and has received on the order of ~448,630 citations.  Other sources such as Research.com report his Medicine discipline D-index ~209 with ~282,315 citations in Medicine alone. Throughout his career he has contributed numerous papers in high‐impact journals, guiding advances in diagnostics, treatments, and understanding of kidney function and disease, and remains a leading figure in Italian and international nephrology research.

Profiles: Orcid | Scopus

Featured Publications:

Perico, L., Casiraghi, F., Benigni, A., & Remuzzi, G. (2025). Is there a place for engineered immune cell therapies in autoimmune diseases? Trends in Molecular Medicine. Advance online publication.

Anandh, U., Anders, H.-J., Bacchetta, J., Johnson, D. W., Luyckx, V., Remuzzi, G., Rodriguez-Iturbe, B., Susztak, K., Tuttle, K., & Yanagita, M. (2025). Two decades of nephrology research: Progress and future challenges. Nature Reviews Nephrology. Advance online publication.

Ghaddar, M., Caravaca-Fontán, F., Praga, M., Fernández-Juárez, G., Lomax-Browne, H. J., Cook, H. T., Daina, E., Noris, M., Remuzzi, G., Induruwage, D., & colleagues. (2025). Clinical and histologic predictors of kidney outcomes in C3 glomerulopathy and idiopathic membranoproliferative GN. Clinical Journal of the American Society of Nephrology. Advance online publication.

Pezzotta, A., Perico, L., Morigi, M., Corna, D., Locatelli, M., Zoja, C., Benigni, A., Remuzzi, G., Imberti, B., & colleagues. (2025). Correction: Low nephron number induced by maternal protein restriction is prevented by nicotinamide riboside supplementation depending on sirtuin 3 activation. Cells, 14(17), 1328.

Zoccali, C., Provenzano, P. F., Tripepi, G., Carrara, F., Mallamaci, F., Perna, A., Delanaye, P., Ruggenenti, P., & Remuzzi, G. (2025). Reliability of GFR estimated by creatinine-based formulas in moderate-to-severe proteinuria. Clinical Journal of the American Society of Nephrology. Advance online publication.

Zoccali, C., Mallamaci, F., Lightstone, L., Jha, V., Pollock, C., Tuttle, K., Kotanko, P., Wiecek, A., Anders, H.-J., Remuzzi, G., & colleagues. (2024). A new era in the science and care of kidney diseases. Nature Reviews Nephrology, 20(7), 439–453.

Evgeny Deforzh | Cancer | Best Researcher Award

Published on by Cell Biologist

Dr. Evgeny Deforzh | Cancer | Best Researcher Award

Brigham and Women’s Hospital, Harvard University | United States

Dr. Evgeny Deforzh is a molecular biologist whose work focuses on the regulation of RNA, microRNAs, chromatin dynamics, and their roles in cancer and neurological disease. After earning his B.S. and M.S. in Biology from Saint Petersburg State University and a Ph.D. in Molecular Biology from Paris‑Saclay University, he completed postdoctoral research as a Research Fellow and subsequently served as Instructor in Neurology at Brigham & Women’s Hospital. His peer‑reviewed contributions include insights into how WEE1 regulators switch roles in cell cycle control, protection of cyclin mRNAs from translational repression, the impact of glioblastoma‑derived extracellular vesicles on astrocyte transformation, and the nuclear modulation of splicing by oncogenic microRNAs. More recently, his work has elucidated promoter/enhancer RNA regulation of super‑enhancers, and miRNA pathways as therapeutic targets in gliomas and meningiomas. To date, Dr. Deforzh has published ~15–20 independent original research articles (first‑, co‑first, or senior‑author) with many additional co‐authored papers. His publications have been cited in the literature ~800‑1,200 times, giving him an approximate h‑index of 12–15. His research has advanced understanding of RNA regulatory networks in cancer and offers potential translational pathways for diagnostics and therapy.

Profiles: Google Scholar | Scopus

Featured Publications:

Zeng, A., Wei, Z., Rabinovsky, R., Jun, H. J., El Fatimy, R., Deforzh, E., & Arora, R. (2020). Glioblastoma-derived extracellular vesicles facilitate transformation of astrocytes via reprogramming oncogenic metabolism. iScience, 23(8), 101420.

Deforzh, E., Uhlmann, E. J., Das, E., Galitsyna, A., Arora, R., Saravanan, H., … (2022). Promoter and enhancer RNAs regulate chromatin reorganization and activation of miR-10b/HOXD locus, and neoplastic transformation in glioma. Molecular Cell, 82(10), 1894–1908.e5.

El Fatimy, R., Zhang, Y., Deforzh, E., Ramadas, M., Saravanan, H., Wei, Z., … (2022). A nuclear function for an oncogenic microRNA as a modulator of snRNA and splicing. Molecular Cancer, 21(1), 17.

Poller, W., Sahoo, S., Hajjar, R., Landmesser, U., & Krichevsky, A. M. (2023). Exploration of the noncoding genome for human-specific therapeutic targets—Recent insights at molecular and cellular level. Cells, 12(22), 2660.

Deforzh, E., Vargas, T. R., Kropp, J., Vandamme, M., Pinna, G., & Polesskaya, A. (2016). IMP-3 protects the mRNAs of cyclins D1 and D3 from GW182/AGO2-dependent translational repression. International Journal of Oncology, 49(6), 2578–2588.

Kratassiouk, G., Pritchard, L. L., Cuvellier, S., Vislovukh, A., Meng, Q., … (2016). The WEE1 regulators CPEB1 and miR-15b switch from inhibitor to activators at G2/M. Cell Cycle, 15(5), 667–677.

Xinghua Pan | Single Cell and Spatial Omics | Excellence in Research Award

Published on by Cell Biologist

Prof. Xinghua Pan | Single Cell and Spatial Omics | Excellence in Research Award

Macau University of Science and Technology | China

Professor Xinghua (Victor) Pan, PhD, MD, is a distinguished researcher in the fields of single-cell technology, spatial omics, genome medicine, regenerative biology, and cancer heterogeneity. Currently serving as a professor at the Precision Regenerative Medicine Research Centre (PRMRC), Macau University of Science and Technology (MUST), he is also affiliated with the State Key Laboratory of Quality Research in Chinese Medicine. Dr. Pan earned his MD and MS degrees from Southern Medical University and completed his PhD in genetics at Fudan University under the mentorship of renowned geneticist Dr. CC Tan. His interdisciplinary research integrates cutting-edge single-cell and multi-omics platforms to investigate tumor microenvironments, stemness, and disease mechanisms at cellular resolution. Dr. Pan has authored over 280 peer-reviewed publications, with a current h-index of 48, more than 9,200 citations, and his work spans high-impact journals such as Nature, Nature Communications, Advanced Science, Nucleic Acids Research, and Cancer Research. He is frequently recognized as a corresponding or co-corresponding author in key studies advancing genomic technologies and translational applications in precision medicine. His contributions continue to shape the landscape of cellular and molecular research globally.

Profiles: Google Scholar | Orcid

Featured Publications:

Zhang, Y., Lu, Y., Mai, L., Wen, Z., Dai, M., Xu, S., Lin, X., Luo, Y., Qiu, Y., Chen, Y., Dong, Z., Chen, C., Meng, W., Luo, X., Lin, G., Tam, P. K. H., & Pan, X. (2025). Dynamic heterogeneity towards drug resistance in AML cells is primarily driven by epigenomic mechanism unveiled by multi-omics analysis. Journal of Advanced Research. Advance online publication.

Su, H., Zhou, X., Lin, G., Luo, C., Meng, W., Lv, C., Chen, Y., Wen, Z., Li, X., Wu, Y., Xiao, C., Yang, J., Lu, J., Luo, X., Hong, X., Chen, Y., Tam, P. K. H., Li, C., Sun, H., & Pan, X. (2025). Deciphering the oncogenic landscape of hepatocytes through integrated single-nucleus and bulk RNA-seq of hepatocellular carcinoma. Advanced Science, 12, e2412944.

Huang, Y., Wang, Q., Zhou, W., Jiang, Y., He, K., Huang, W., Feng, Y., Wu, H., Liu, L., Pan, Y., Huang, Y., Chen, Z., Li, W., Huang, Y., Lin, G., Zhang, Y., Ren, Y., Xu, K., Yu, Y., … Hu, Y. (2024). Prenatal p25-activated Cdk5 induces pituitary tumorigenesis through MCM2 phosphorylation-mediated cell proliferation. Neoplasia, 57, 101054.

Gao, J., Wu, Y., Yu, J., Qiu, Y., Yi, T., Luo, C., Zhang, J., Lu, G., Li, X., Xiong, F., Wu, X., & Pan, X. (2024). Impact of genomic and epigenomic alterations of multigene on a multicancer pedigree. Cancer Medicine, 13(13), e7394.

Chen, F., Zhang, K., Wang, M., He, Z., Yu, B., Wang, X., Pan, X., Luo, Y., Xu, S., Lau, J. T. Y., Han, C., Shi, Y., Sun, Y. E., Li, S., & Hu, Y. P. (2024). VEGF-FGF signaling activates quiescent CD63(+) liver stem cells to proliferate and differentiate. Advanced Science, 11, e2308711.

Mai, L., Wen, Z., Zhang, Y., Gao, Y., Lin, G., Lian, Z., Yang, X., Zhou, J., Lin, X., Luo, C., Peng, W., Chen, C., Peng, J., Liu, D., Marjani, S. L., Tao, Q., Cui, Y., Zhang, J., Wu, X., Weissman, S. M., & Pan, X. (2023). Shortcut barcoding and early pooling for scalable multiplex single-cell reduced-representation CpG methylation sequencing at single nucleotide resolution. Nucleic Acids Research, 51, e108.

Rachel Foster | Microbial Oceanography | Best Researcher Award

Published on by Cell Biologist

Prof. Rachel Foster | Microbial Oceanography | Best Researcher Award

Stockholm University | Sweden

Rachel A. Foster is a leading researcher in microbial oceanography, with significant contributions to the study of planktonic symbioses, particularly those involving nitrogen-fixing cyanobacteria and diatoms. Her research focuses on the evolution, function, and genomic innovations of symbiotic microorganisms that drive key biogeochemical cycles in marine ecosystems. Foster has pioneered single-cell approaches, including mass spectrometry imaging and heterologous gene expression, to uncover molecular interactions between symbiotic partners. She has secured major national and international grants, including from the Swedish Research Council, SciLifeLab, Formas, and the Wallenberg Foundation, supporting both basic and applied research. She has published 71 peer-reviewed works, including 3 book chapters, with 31 as first or senior author, and her work has been cited 5,944 times. Her current h-index is 40, demonstrating both the depth and influence of her scholarship. Her editorial contributions include serving as Specialty Co-Chief Editor for Frontiers in Aquatic Microbiology. Foster’s recent work includes high-impact publications in Current Biology, The ISME Journal, and PNAS Nexus, as well as openly shared datasets. Through multidisciplinary collaborations across Europe, she continues to shape our understanding of microbial symbioses and their evolutionary significance in the ocean.

Profiles: Scopus | Orcid

Featured Publications:

Grujcic, V., Mehrshad, M., Vigil-Stenman, T., Lundin, D., & Foster, R. A. (2025). Stepwise genome evolution from a facultative symbiont to an endosymbiont in the N2-fixing diatom-Richelia symbioses. Current Biology.

Nieves-Morión, M., Romero-García, R., Bardi, S., López-Maury, L., Hagemann, M., Flores, E., & Foster, R. A. (2025). Retention of a SulP-family bicarbonate transporter in a periplasmic N2-fixing cyanobacterial endosymbiont of an open ocean diatom. The ISME Journal.

Foster, R. A. (2025, April 27). Molecular markers for Richelia symbionts of open ocean diatom symbioses [Dataset]. figshare.

Grujcic, V., Mehrshad, M., Vigil-Stenman, C. T., Lundin, D., & Foster, R. A. (2025, March 25). The path to dependence: Stepwise genome evolution from a facultative symbiont to an endosymbiont in the N2-fixing diatom-Richelia symbioses [Preprint]. bioRxiv.

Nieves-Morión, M., Romero-García, R., Bardi, S., López-Maury, L., Hagemann, M., Flores, E., & Foster, R. A. (2024, January 10). Using gene complementation to identify a SulP-family bicarbonate transporter in an N2-fixing cyanobacterial endosymbiont of an open ocean diatom [Preprint]. bioRxiv.

Nieves-Morión, M., Camargo, S., Bardi, S., Ruiz, M. T., Flores, E., Foster, R. A., & Bayer, E. (2023). Heterologous expression of genes from a cyanobacterial endosymbiont highlights substrate exchanges with its diatom host. PNAS Nexus.

Kelly Bosak | Stem Cell Research | Best Researcher Award

Published on by Cell Biologist

Dr. Kelly Bosak | Stem Cell Research | Best Researcher Award

University of Kansas Medical Center | United States

Dr. Kelly A. Bosak, PhD, APRN, ANP-BC, FHFSA, is a tenured Associate Professor at the University of Kansas Medical Center and a nationally recognized expert in heart failure care, nursing science, and implementation research. With a strong background in advanced practice nursing and nursing administration, Dr. Bosak has made significant contributions to interdisciplinary research focused on improving clinical outcomes in cardiology, rural health, and chronic disease management. Her peer-reviewed work spans high-impact journals such as The Journal of Cardiac Failure, Implementation Science, and The Journal for Nurse Practitioners, reflecting her leadership in both clinical practice and academic scholarship. Dr. Bosak has authored or co-authored over 30 peer-reviewed publications, with a Scopus h-index of 10, over 450 citations, and 32 documents indexed in major databases. She has played a pivotal role in national reports from the Heart Failure Society of America and led multiple implementation science projects aimed at integrating evidence-based interventions into routine care. Her current research emphasizes digital health innovation and workforce development in underserved communities. Dr. Bosak’s interdisciplinary collaborations and translational research continue to shape evidence-based practice and policy in cardiovascular nursing and advanced practice nursing education.

Profiles: Google Scholar | Scopus

Featured Publications:

  • “Return on Investment of a Nurse Practitioner Fellowship Program”

  • “Interprofessional Education for Improving Workforce Capacity to Treat COPD and Long COVID in Rural Communities”

  • “Shared Decision Making for the Pulmonary Artery Monitoring Device for Patients with Heart Failure”

  • “Implementation of a SmartPhrase for Exercise in the Electronic Health Record for Individuals with Heart Failure”

  • “Implementing a Standardized Workflow for Early Detection of Steroid-Induced Hyperglycemia in Allogeneic Stem Cell Transplant Recipients: A Quality Improvement Project”

  • “Team Science”

  • “Ceramides as Novel Biomarkers of Cardiometabolic Conditions”

  • “Heart Failure Epidemiology and Outcomes Statistics An Updated 2024 Report from the Heart Failure Society of America”

  • “Heart Failure Epidemiology and Outcomes Statistics, A Report of the Heart Failure Society of America”

  • “Implementation Mapping and Concept Mapping to Explore Guideline Implementation in the Heart Failure Clinic”

  • “Coordinating Resources for a Hybrid Effectiveness and Implementation Trial Across an Integrated Digital Network for Heart Failure”

  • “Creating a Standardized Approach to Program Evaluation in a Magnet Recognized Pediatric Hospital System”

 

 

 

Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Ann-Kathrin Eisfeld | Molecular Profiles | Best Researcher Award

The Ohio State University | United States

Dr. Ann-Kathrin Eisfeld is an internationally recognized physician-scientist and Associate Professor with Tenure in the Division of Hematology at The Ohio State University, where she also serves as Director of the Clara D. Bloomfield Center for Leukemia Outcomes Research. Her research focuses on the molecular and genetic underpinnings of acute myeloid leukemia (AML), with a particular emphasis on translational applications that improve patient outcomes. Dr. Eisfeld has published extensively in high-impact journals such as Nature, Leukemia, Blood, and Cell Stem Cell, contributing significantly to our understanding of leukemia biology, clonal evolution, and treatment resistance. she has authored over 100 peer-reviewed scientific publications, with an h-index of 38, more than 6,500 citations, and has led or co-led multiple collaborative studies within national consortia such as the Alliance for Clinical Trials in Oncology. Her work has identified critical biomarkers and therapeutic targets in AML, including insights into TP53 mutations, FLT3 alterations, and resistance mechanisms to venetoclax. Recognized for her integration of clinical insight with cutting-edge genomics, Dr. Eisfeld is a leading voice in precision oncology and leukemia research, shaping the future of individualized treatment strategies through both clinical innovation and scientific discovery.

Profile: Scopus

Featured Publications:

“Highly elevated serum hepcidin in patients with acute myeloid leukemia prior to and after allogeneic hematopoietic cell transplantation: Does this protect from excessive parenchymal iron loading?”

“Heritable polymorphism predisposes to high BAALC expression in acute myeloid leukemia”

“miR-3151 interplays with its host gene BAALC and independently affects outcome of patients with cytogenetically normal acute myeloid leukemia”

“Clinical and pharmacodynamic activity of bortezomib and decitabine in acute myeloid leukemia”

“Kinetics of iron removal by phlebotomy in patients with iron overload after allogeneic hematopoietic cell transplantation”

“inv(16)/t(16;16) acute myeloid leukemia with non-type A CBFB-MYH11 fusions associate with distinct clinical and genetic features and lack KIT mutations”

“Clinical Role of microRNAs in Cytogenetically Normal Acute Myeloid Leukemia: miR-155 Upregulation Independently Identifies High-Risk Patients”

“In rare acute myeloid leukemia patients harboring both RUNX1 and NPM1 mutations, RUNX1 mutations are unusual in structure and present in the germline”

“A stem cell-like gene expression signature associates with inferior outcomes and a distinct microRNA expression profile in adults with primary cytogenetically normal acute myeloid leukemia”

Emine Mine Soylu | Plant Pathology | Best Researcher Award

Published on by Cell Biologist

Prof. Dr. Emine Mine Soylu | Plant Pathology | Best Researcher Award

Hatay Mustafa Kemal University | Turkey

Prof. Dr. Emine Mine Soylu is a prominent academic in the field of plant pathology, with a career spanning over three decades dedicated to plant protection, host-pathogen interactions, and disease management strategies in crops. She began her professional journey as a Research Assistant at Akdeniz University and has since contributed significantly to scientific research through both experimental studies and scholarly publications. Her work is widely recognized, with a particular focus on the identification and control of fungal and bacterial diseases in economically important plants. Prof. Soylu has published 54 scientific documents in internationally refereed journals and has amassed a total of 3,749 citations, reflecting the substantial impact of her work in the field. Her h-index is 25, indicating consistent and high-quality contributions to science over the years. Her research includes first reports of various plant diseases in Türkiye and in-depth studies on disease resistance mechanisms and biochemical plant responses. Prof. Soylu’s contributions continue to shape the future of sustainable agriculture and plant health, and her collaborations extend across national and international scientific communities. Her scholarly output and citation metrics demonstrate her strong influence in the field of phytopathology and plant-microbe interactions.

Profiles: Google Scholar | Scopus |  Orcid

Featured Publications:

  • “Preliminary Characterization of Race-Specific Elicitors From Peronospora parasitica and Its Ability to Elicit Phenolic Accumulation in Arabidopsis”

  • “First Report of Downy Leaf Spot of Walnuts Caused by Microstroma juglandis in Turkey”

  • “Induction of Disease Resistance by the Plant Activator, Acibenzolar-S-methyl (ASM), Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato Seedlings”

  • “First Report of Powdery Mildew Caused by Erysiphe heraclei on Dill (Anethum graveolens) in Turkey”

  • “Light and Electron Microscopy of the Compatible Interaction Between Arabidopsis and the Downy Mildew Pathogen Peronospora parasitica”

  • “Induction of Defence Related Enzymes and Resistance by the Plant Activator Acibenzolar-S-methyl in Tomato Seedlings Against Bacterial Canker Caused by Clavibacter michiganensis subsp. michiganensis”

  • “First Report of Cercospora Leaf Spot on Swiss Chard Caused by Cercospora beticola in Turkey”

  • “First Report of Phloeospora Leaf Spot on Mulberry Caused by Phloeospora maculans (=Cylindrosporium maculans) in the Eastern Mediterranean Region of Turkey”

  • “Induction of Disease Resistance and Antioxidant Enzymes by Acibenzolar-S-methyl Against Bacterial Canker (Clavibacter michiganensis subsp. michiganensis) in Tomato”

  • “First Report of Powdery Mildew Caused by Podosphaera phaseoli (syn. Sphaerotheca phaseoli) on Cowpea (Vigna sinensis) in Turkey”